-
1
-
-
0032779988
-
Inhibition of cell growth and induction of apoptotic cell death by the human tumor-associated antigenRCAS1
-
Nakashima M, Sonoda K, Watanabe T: Inhibition of cell growth and induction of apoptotic cell death by the human tumor-associated antigenRCAS1. Nature Med 5:938-942, 1999
-
(1999)
Nature Med
, vol.5
, pp. 938-942
-
-
Nakashima, M.1
Sonoda, K.2
Watanabe, T.3
-
2
-
-
0029966641
-
A novel tumor-associated antigen expressed in human uterine and ovarian carcinomas
-
Sonoda K, Nakashima M, Kaku T, Kamura T, Nakano H, Watanabe T: A novel tumor-associated antigen expressed in human uterine and ovarian carcinomas. Cancer 77:1501-1509, 1996
-
(1996)
Cancer
, vol.77
, pp. 1501-1509
-
-
Sonoda, K.1
Nakashima, M.2
Kaku, T.3
Kamura, T.4
Nakano, H.5
Watanabe, T.6
-
3
-
-
0031747728
-
Tumor-associated antigen 22-1-1 expression in the uterine cervical squamous neoplasias
-
Sonoda K, Kaku T, Kamura T, Nakashima M, Watanabe T, Nakano H: Tumor-associated antigen 22-1-1 expression in the uterine cervical squamous neoplasias. Clin Cancer Res 4:1517-1520, 1998
-
(1998)
Clin Cancer Res
, vol.4
, pp. 1517-1520
-
-
Sonoda, K.1
Kaku, T.2
Kamura, T.3
Nakashima, M.4
Watanabe, T.5
Nakano, H.6
-
4
-
-
0036623483
-
The tumor-associated antigen, RCAS1, can be expressed in immune-mediated diseases as well as in carcinomas of the biliary tract
-
Enjoji M, Nakashima M, Nishi H, Choi I, Oimomi H, Sugimoto R, Kotoh K, Taguchi K, Nakamuta M, Nawata H, Watanabe T: The tumor-associated antigen, RCAS1, can be expressed in immune-mediated diseases as well as in carcinomas of the biliary tract. J Hepatol 36:786-792, 2002
-
(2002)
J Hepatol
, vol.36
, pp. 786-792
-
-
Enjoji, M.1
Nakashima, M.2
Nishi, H.3
Choi, I.4
Oimomi, H.5
Sugimoto, R.6
Kotoh, K.7
Taguchi, K.8
Nakamuta, M.9
Nawata, H.10
Watanabe, T.11
-
5
-
-
0037216504
-
Expression and diagnostic evaluation of the human tumor-associated antigen RCAS1 in pancreatic cancer
-
Akashi T, Oimomi H, Nishiyama K, Nakashima M, Arita Y, Sumii T, Kimura T, Ito T, Nawata H, Watanabe T: Expression and diagnostic evaluation of the human tumor-associated antigen RCAS1 in pancreatic cancer. Pancreas 26:49-55, 2003
-
(2003)
Pancreas
, vol.26
, pp. 49-55
-
-
Akashi, T.1
Oimomi, H.2
Nishiyama, K.3
Nakashima, M.4
Arita, Y.5
Sumii, T.6
Kimura, T.7
Ito, T.8
Nawata, H.9
Watanabe, T.10
-
6
-
-
12444315017
-
Clinical significance of serum RCAS1 levels detected by monoclonal antibody 22-1-1 in patients with cholangiocellular carcinoma
-
Watanabe H, Enjoji M, Nakashima M, Noguchi K, Kinukawa N, Sugimoto R, Kotoh K, Nakamuta M, Nawata H, Watanabe T: Clinical significance of serum RCAS1 levels detected by monoclonal antibody 22-1-1 in patients with cholangiocellular carcinoma. J Hepatol 39:559-563, 2003
-
(2003)
J Hepatol
, vol.39
, pp. 559-563
-
-
Watanabe, H.1
Enjoji, M.2
Nakashima, M.3
Noguchi, K.4
Kinukawa, N.5
Sugimoto, R.6
Kotoh, K.7
Nakamuta, M.8
Nawata, H.9
Watanabe, T.10
-
7
-
-
0023895365
-
Tumor markers carbohydrate antigens CA19-9 and CA50 and carcinoembryonic antigen in pancreatic cancer and benign diseases of the pancreatobiliary tract
-
Harmenberg U, Wahren B, Wiechel KL: Tumor markers carbohydrate antigens CA19-9 and CA50 and carcinoembryonic antigen in pancreatic cancer and benign diseases of the pancreatobiliary tract. Cancer Res 48:1985-1988, 1988
-
(1988)
Cancer Res
, vol.48
, pp. 1985-1988
-
-
Harmenberg, U.1
Wahren, B.2
Wiechel, K.L.3
-
8
-
-
0023903792
-
CA19-9 and CA50 in benign and malignant pancreatic and biliary diseases
-
Paganuzzi M, Onetto M, Marroni P, Barone D, Conio M, Aste H, Pugliese V: CA19-9 and CA50 in benign and malignant pancreatic and biliary diseases. Cancer 61:2100-2108, 1988
-
(1988)
Cancer
, vol.61
, pp. 2100-2108
-
-
Paganuzzi, M.1
Onetto, M.2
Marroni, P.3
Barone, D.4
Conio, M.5
Aste, H.6
Pugliese, V.7
-
9
-
-
0025307965
-
The clinical utility of the CA19-9 tumor-associated antigen
-
Steinberg W: The clinical utility of the CA19-9 tumor-associated antigen. Am J Gastroenterol 85:350-355, 1990
-
(1990)
Am J Gastroenterol
, vol.85
, pp. 350-355
-
-
Steinberg, W.1
-
10
-
-
0025781243
-
CA19-9 estimation in the assessment of pancreatic or biliary tract malignancy-What is the most efficient threshold value?
-
Welfare M, Tannar A: CA19-9 estimation in the assessment of pancreatic or biliary tract malignancy-What is the most efficient threshold value? Eur J Gastroenterol Hepatol 3:539-543, 1991
-
(1991)
Eur J Gastroenterol Hepatol
, vol.3
, pp. 539-543
-
-
Welfare, M.1
Tannar, A.2
-
11
-
-
0021345134
-
Comparison of a new tumor marker, CA19-9, with a-fetoprotein and carcinoembryonic antigen in patients with upper gastrointestinal diseases
-
Jalanko H, Kuusela P, Roberts P, Sipponen P, Haglund C, Makela O: Comparison of a new tumor marker, CA19-9, with a-fetoprotein and carcinoembryonic antigen in patients with upper gastrointestinal diseases. J Clin Pathol 37:218-222, 1984
-
(1984)
J Clin Pathol
, vol.37
, pp. 218-222
-
-
Jalanko, H.1
Kuusela, P.2
Roberts, P.3
Sipponen, P.4
Haglund, C.5
Makela, O.6
-
12
-
-
0036179385
-
RCAS1 expression in immune-mediated liver diseases
-
Enjoji M, Nakamuta M, Noguchi K, Sugimoto R, Kotoh K, Nawata H, Nakashima M, Watanabe T: RCAS1 expression in immune-mediated liver diseases. J Clin Gastroenterol 34:286-287, 2002
-
(2002)
J Clin Gastroenterol
, vol.34
, pp. 286-287
-
-
Enjoji, M.1
Nakamuta, M.2
Noguchi, K.3
Sugimoto, R.4
Kotoh, K.5
Nawata, H.6
Nakashima, M.7
Watanabe, T.8
-
13
-
-
5044226482
-
Movement of a novel serum tumor marker, RCAS1, in patients with biliary diseases
-
Enjoji M, Yamaguchi K, Nakamuta M, Nakashima M, Kotoh K, Tanaka M, Nawata H, Watanabe T: Movement of a novel serum tumor marker, RCAS1, in patients with biliary diseases. Digest Liver Dis 36:622-627, 2004
-
(2004)
Digest Liver Dis
, vol.36
, pp. 622-627
-
-
Enjoji, M.1
Yamaguchi, K.2
Nakamuta, M.3
Nakashima, M.4
Kotoh, K.5
Tanaka, M.6
Nawata, H.7
Watanabe, T.8
|